U.S. market Closed. Opens in 1 day 5 hours 14 minutes

BCLI | Brainstorm Cell Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-03-312004-03-312003-03-312002-03-31
RevenueN/AN/AN/AN/A-366.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A82.89K22.90K
Cost of Revenue265.00K285.00K260.00K219.00K366.00K110.00K85.00K77.00K87.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A71.70K17.30K
Gross Profit-265.00K-285.00K-260.00K-219.00K-732.00K-110.00K-85.00K-77.00K-87.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A11.19K5.60K
Operating Expenses21.17M24.82M24.54M31.68M23.00M14.06M5.00M5.08M8.54M7.42M5.02M3.52M3.89M2.59M1.75M3.27M4.92M2.88M18.83M70.95K57.99K38.29K
Selling, General & Admin10.69M10.87M9.30M9.36M5.80M5.77M4.02M2.83M3.59M2.65M2.10M1.75M2.21M1.54M1.57M1.63M2.99M2.14M2.48M47.23K36.42K23.80K
Research & Development10.48M13.96M15.23M22.33M17.20M8.29M977.00K2.25M4.95M4.77M2.92M1.77M1.69M1.04M181.00K1.64M1.93M741.92K16.35MN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A23.71K21.57K14.49K
Operating Income-21.44M-24.82M-24.54M-31.68M-23.00M-14.06M-5.00M-5.08M-8.54M-7.42M-4.87M-3.42M-3.89M-2.40M-1.75M-3.27M-4.92M-2.88M-18.83M-70.95K-46.81K-33.23K
Other Expenses / Income4.25M545.00K82.00K-127.00K-252.00K115.00K47.00K101.00K48.00K-1.82M169.00K93.00K-19.00K189.00K-45.00K-287.00K-1.37M-1.89M-6.00K-18.76M-26.49K14.12K
Before Tax Income-17.19M-24.28M-24.46M-31.81M-23.25M-13.95M-4.95M-4.98M-8.49M-9.25M-4.87M-3.42M-3.91M-2.40MN/A-3.47M-6.24M-3.91M-18.83MN/AN/A-32.69K
Income Tax ExpensesN/A-545.00K-82.00K127.00K252.00K-115.00K-47.00K-101.00K-48.00K-1.82M25.00K5.00K5.00K19.00K31.00K204.00K1.33M17.22K5.47K2.35KN/A-7.67K
Net Income-17.19M-23.73M-24.38M-31.94M-23.50M-13.83M-4.95M-4.98M-8.49M-9.25M-4.90M-3.43M-3.92M-2.42M-1.78M-3.47M-6.24M-3.92M-18.84M-73.30K-46.81K-25.56K
Interest ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A151.00KN/A31.00K204.00K1.33M1.03M7.28KN/AN/AN/A
Basic Shares Outstanding42.98M36.51M36.18M29.85M21.91M20.00M18.78M18.66M18.41M13.66M10.74M9.17M8.01M5.94M4.08M3.27M1.95M1.58M1.24M1.14M1.35M2.69M
Diluted Shares Outstanding43.08M36.51M36.18M29.85M21.91M20.00M18.78M18.66M18.41M13.66M10.74M9.17M8.01M5.94M4.08M3.27M1.95M1.58M1.24M1.14M1.35M2.69M
EBITDA-16.93M-23.99M-24.28M-31.46M-23.09M-13.84M-4.87M-4.91M-8.40M-7.32M-4.78M-3.27M-3.57M-2.24M-1.58M-3.12M-4.75M-766.10K-18.24M-18.83M-47.23K-25.23K
EBITDA Margin0.00%0.00%0.00%0.00%6,308.47%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-56.98%-110.20%
EBIT-17.19M-24.28M-24.46M-31.81M-23.25M-13.95M-5.00M-5.08M-8.54M-11.07M-4.87M-3.42M-3.76M-2.40M-1.72M-3.06M-3.59M-2.88M-18.83M-70.95K-46.81K-33.23K
EBIT Margin0.00%0.00%0.00%0.00%6,353.28%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-56.47%-145.09%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-03-312004-03-312003-03-312002-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙